Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Clinical Perspectives on the Treatment Evolution of Resectable Early-Stage NSCLC

Wednesday, 11:30 – 12:30
View the satellite invitation

Navigating the Metastatic NSCLC Treatment Landscape: Addressing Hard-to-Treat Tumours

Saturday, 8:00 – 9:30
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Clinical Perspectives on the Treatment Evolution of Resectable Early-Stage NSCLC

Tumor Treating Fields Therapy: A Force for Change in Lung Cancer

TROP-2–Targeted ADCs for NSCLC: Integrating a New Therapeutic Option

Guiding Clinical Decision-Making in Advanced EGFR-Mutant NSCLC

Shaping the Future of ALK+ NSCLC: What’s the Next Leap Forward?

Advancing Therapeutic Strategies in Lung Cancer Care

Current Approaches and Future Strategies in Non-Oncogene Driven Advanced NSCLC

From Paper to Practice: Exploring Advances in Early-Stage NSCLC

Targeting Rare Mutations in NSCLC: A Focus on HER2m

The Critical Role of Timely Genomic Profiling in NSCLC

Moving Forward in Metastatic NSCLC: The Role of ADCs

Navigating the Metastatic NSCLC Treatment Landscape: Addressing Hard-to-Treat Tumours